Ranbaxy Laboratories has received approval in India for lamivudine/stavudine/nevirapine to treat children with HIV infections.

Source: Inpharma, Volume 1, Number 1551, 2006-08-19 , pp. 23-23(1)

Publisher: Adis International

Keywords: Children; Development-status; Generic-substitution; HIV-infections, treatment; Lamivudine/stavudine/nevirapine, therapeutic use; Product-approvals; Research-and-development

Document Type: Short communication

Publication date: 2006-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers